Acadia Healthcare Company, Inc. (ACHC)
USD 39.05
(-1.49%)
USD 39.05
(-1.49%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -21.66 Million USD | -107.93% |
| 2022 | 273.13 Million USD | 43.28% |
| 2021 | 190.63 Million USD | 33.13% |
| 2020 | 143.19 Million USD | 31.46% |
| 2019 | 108.92 Million USD | 161.98% |
| 2018 | -175.75 Million USD | -187.95% |
| 2017 | 199.83 Million USD | 3153.05% |
| 2016 | 6.14 Million USD | -94.86% |
| 2015 | 119.54 Million USD | 43.96% |
| 2014 | 83.04 Million USD | 95.03% |
| 2013 | 42.57 Million USD | 108.69% |
| 2012 | 20.4 Million USD | 158.47% |
| 2011 | -34.89 Million USD | -661.87% |
| 2010 | 6.21 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 68.13 Million USD | -13.19% |
| 2024 Q1 | 76.38 Million USD | 32.31% |
| 2024 Q2 | 78.48 Million USD | 2.75% |
| 2023 Q3 | -217.71 Million USD | -401.12% |
| 2023 Q4 | 57.72 Million USD | 126.52% |
| 2023 Q2 | 72.29 Million USD | 9.52% |
| 2023 FY | -21.66 Million USD | -107.93% |
| 2023 Q1 | 66.01 Million USD | 8.0% |
| 2022 Q3 | 71.09 Million USD | -11.21% |
| 2022 Q1 | 60.83 Million USD | -13.43% |
| 2022 Q4 | 61.12 Million USD | -14.03% |
| 2022 FY | 273.13 Million USD | 43.28% |
| 2022 Q2 | 80.07 Million USD | 31.63% |
| 2021 Q2 | 44.51 Million USD | 358.1% |
| 2021 Q4 | 70.27 Million USD | 6.28% |
| 2021 Q3 | 66.12 Million USD | 48.55% |
| 2021 Q1 | 9.71 Million USD | 101.24% |
| 2021 FY | 190.63 Million USD | 33.13% |
| 2020 Q1 | 33.46 Million USD | 397.34% |
| 2020 FY | 143.19 Million USD | 31.46% |
| 2020 Q2 | 41.07 Million USD | 22.76% |
| 2020 Q3 | 36.99 Million USD | -9.93% |
| 2020 Q4 | -783.67 Million USD | -2218.15% |
| 2019 FY | 108.92 Million USD | 161.98% |
| 2019 Q2 | 48.14 Million USD | 63.35% |
| 2019 Q3 | 42.56 Million USD | -11.58% |
| 2019 Q4 | -11.25 Million USD | -126.44% |
| 2019 Q1 | 29.47 Million USD | 108.89% |
| 2018 FY | -175.75 Million USD | -187.95% |
| 2018 Q4 | -331.63 Million USD | -817.33% |
| 2018 Q3 | 46.23 Million USD | -21.42% |
| 2018 Q2 | 58.83 Million USD | 15.78% |
| 2018 Q1 | 50.81 Million USD | -27.01% |
| 2017 Q4 | 69.62 Million USD | 52.63% |
| 2017 Q1 | 34.95 Million USD | -16.4% |
| 2017 FY | 199.83 Million USD | 3153.05% |
| 2017 Q2 | 49.63 Million USD | 41.97% |
| 2017 Q3 | 45.61 Million USD | -8.08% |
| 2016 FY | 6.14 Million USD | -94.86% |
| 2016 Q3 | -117.8 Million USD | -308.71% |
| 2016 Q1 | 25.68 Million USD | -38.19% |
| 2016 Q2 | 56.44 Million USD | 119.73% |
| 2016 Q4 | 41.81 Million USD | 135.5% |
| 2015 FY | 119.54 Million USD | 43.96% |
| 2015 Q4 | 41.55 Million USD | 40.63% |
| 2015 Q3 | 29.55 Million USD | -12.69% |
| 2015 Q2 | 33.84 Million USD | 131.9% |
| 2015 Q1 | 14.59 Million USD | -34.05% |
| 2014 Q4 | 22.12 Million USD | -12.88% |
| 2014 Q2 | 22.45 Million USD | 71.93% |
| 2014 Q3 | 25.4 Million USD | 13.14% |
| 2014 Q1 | 13.05 Million USD | 6.34% |
| 2014 FY | 83.04 Million USD | 95.03% |
| 2013 Q4 | 12.28 Million USD | -14.51% |
| 2013 Q1 | 3.73 Million USD | -14.36% |
| 2013 Q2 | 12.19 Million USD | 226.3% |
| 2013 FY | 42.57 Million USD | 108.69% |
| 2013 Q3 | 14.36 Million USD | 17.77% |
| 2012 Q2 | 5.9 Million USD | 60.61% |
| 2012 Q3 | 6.45 Million USD | 9.16% |
| 2012 Q1 | 3.67 Million USD | 123.13% |
| 2012 Q4 | 4.36 Million USD | -32.33% |
| 2012 FY | 20.4 Million USD | 158.47% |
| 2011 Q4 | -15.9 Million USD | -609.41% |
| 2011 Q2 | -21.85 Million USD | -8677.91% |
| 2011 FY | -34.89 Million USD | -661.87% |
| 2011 Q1 | -249 Thousand USD | -147.52% |
| 2011 Q3 | 3.12 Million USD | 114.29% |
| 2010 Q4 | 524 Thousand USD | -66.54% |
| 2010 Q3 | 1.56 Million USD | 0.0% |
| 2010 FY | 6.21 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Addus HomeCare Corporation | 62.51 Million USD | 134.658% |
| AirSculpt Technologies, Inc. | -4.47 Million USD | -383.746% |
| Amedisys, Inc. | -9.74 Million USD | -122.294% |
| American Oncology Network, Inc. | -5.54 Million USD | -290.96% |
| Astrana Health, Inc. | 60.71 Million USD | 135.685% |
| Aveanna Healthcare Holdings Inc. | -134.52 Million USD | 83.894% |
| IMAC Holdings, Inc. | - USD | Infinity% |
| biote Corp. | 3.31 Million USD | 753.408% |
| Cryo-Cell International, Inc. | -9.52 Million USD | -127.555% |
| Cross Country Healthcare, Inc. | 72.63 Million USD | 129.832% |
| COMPASS Pathways plc | -118.46 Million USD | 81.71% |
| DocGo Inc. | 6.85 Million USD | 415.917% |
| The Ensign Group, Inc. | 209.39 Million USD | 110.347% |
| Healthcare Services Group, Inc. | 38.38 Million USD | 156.445% |
| InnovAge Holding Corp. | -21.33 Million USD | -1.542% |
| Assure Holdings Corp. | -26.07 Million USD | 16.915% |
| The Joint Corp. | -9.75 Million USD | -122.176% |
| LifeStance Health Group, Inc. | -186.26 Million USD | 88.367% |
| Mobile-health Network Solutions Class A Ordinary Shares | -15.6 Million USD | -38.866% |
| ModivCare Inc. | -204.46 Million USD | 89.403% |
| NewGenIvf Group Limited | 130.19 Thousand USD | 16742.216% |
| Novo Integrated Sciences, Inc. | -13.21 Million USD | -63.963% |
| Option Care Health, Inc. | 267.09 Million USD | 108.112% |
| P3 Health Partners Inc. | -57.77 Million USD | 62.496% |
| P3 Health Partners Inc. | -57.77 Million USD | 62.496% |
| The Pennant Group, Inc. | 13.37 Million USD | 261.948% |
| Surgery Partners, Inc. | -11.9 Million USD | -82.076% |
| Syra Health Corp. Class A Common Stock | -2.93 Million USD | -637.388% |
| Talkspace, Inc. | -19.18 Million USD | -12.955% |
| Talkspace, Inc. | -19.18 Million USD | -12.955% |
| The Oncology Institute, Inc. | -83.06 Million USD | 73.917% |
| The Oncology Institute, Inc. | -83.06 Million USD | 73.917% |